Oncology & Cancer

Deadliest cancers may respond to new drug treatment strategy

UC San Francisco researchers have found a way to knock down cancers caused by a tumor-driving protein called "myc," paving the way for patients with myc-driven cancers to enroll in clinical trials for experimental treatments.

Oncology & Cancer

Thwarting protein production slows cancer cells' malignant march

Protein production or translation is tightly coupled to a highly conserved stress response that cancer cells rely on for survival and proliferation, according to Whitehead Institute researchers. In mouse models of cancer, ...

Health

New research demonstrates an increase in NHS productivity

A new study by researchers at the Centre for Health Economics, University of York, reveals the productivity of the NHS in England increased by 3.2 per cent in the first year of the Coalition administration.

Medical research

Researchers discover endogenous antibiotic in the brain

Scientists from the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have discovered that immune cells in the brain can produce a substance that prevents bacterial growth: namely itaconic acid. ...

Oncology & Cancer

New biomarker may help in detecting gliomas

Researchers using sophisticated genetic testing techniques have identified a promising new biomarker for diagnosis of glioma—the most common type of malignant brain tumor, reports the January issue of Neurosurgery, official ...

page 5 from 6